Stock-Based Compensation (Tables)
12 Months Ended
Apr. 01, 2017
Stock-Based Compensation  
Schedule of assumptions used to determine fair value of stock options

The fair values of stock options granted in fiscal 2017, 2016 and 2015 were estimated on the grant dates using the following assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Year Ended

 

 

April 1,

 

March 26,

 

March 28,

 

 

2017

    

2016

    

2015

    

Expected option term(1)

 

 

 

5.5

years  

 

 

 

5.5

years  

 

 

 

5.5

years  

Expected volatility factor(2)

35.8

%

-

36.0

%  

33.3

%

-

36.7

%  

37.0

%

-

56.2

%  

Risk-free interest rate(3)

 

 

 

1.4

%  

1.3

%

-

1.8

%  

1.4

%

-

2.0

%  

Expected annual dividend yield(4)

 

 

 

0

%

 

 

 

0

%

 

 

 

0

%

 


(1)

The Company has limited historical information regarding expected option term. Accordingly, the Company determined the expected life of the options using the simplified method.

(2)

Stock volatility for each grant is measured using the weighted average of historical daily price changes of the Company’s competitors’ common stock over the most recent period equal to the expected option term of the Company’s awards.

(3)

The risk‑free interest rate is determined using the rate on treasury securities with the same term.

(4)

The Company’s board of directors does not plan to pay cash dividends in the foreseeable future. Consequently, we used an expected dividend yield of zero.

Schedule of stock award activity

The following table summarizes the stock award activity for the fiscal year ended April 1, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

   

 

 

   

Weighted

   

 

 

 

 

 

 

 

Grant Date

 

Average

 

 

 

 

 

 

 

 

Weighted

 

Remaining

 

Aggregate

 

 

 

Stock

 

Average

 

Contractual

 

Intrinsic

 

 

   

Options

   

Exercise Price(1)

   

Life (in Years)

   

Value

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

Outstanding at March 26, 2016

 

2,447,133

 

$

9.87

 

 

 

 

 

 

Granted

 

560,892

 

$

7.38

 

 

 

 

 

 

Exercised

 

(210,177)

 

$

6.05

 

 

 

$

1,208

 

Cancelled, forfeited or expired

 

(254,188)

 

$

13.27

 

 

 

 

 

 

Outstanding at April 1, 2017

 

2,543,660

 

$

9.29

 

5.9

 

$

6,475

 

Vested and expected to vest after April 1, 2017

 

2,543,660

 

$

9.29

 

5.9

 

$

6,475

 

Exerciseable at April 1, 2017

 

1,395,160

 

$

7.64

 

5.4

 

$

4,463

 

 


(1)

The grant date weighted-average exercise price reflects the reduction of the exercise price by $2.00 per share for the 1,918,550 unvested options that were part of the April 2014 dividend discussed above.

Schedule of non-vested stock options

A summary of the status of non-vested stock options as of April 1, 2017 and changes during fiscal 2017 is presented below:

 

 

 

 

 

 

 

 

   

 

   

Weighted-

 

 

 

 

 

Average

 

 

 

 

 

Grant Date

 

 

   

Shares

   

Fair Value

 

Nonvested at March 26, 2016

 

1,335,103

 

$

5.82

 

Granted

 

560,892

 

$

2.60

 

Vested

 

(535,199)

 

$

4.41

 

Nonvested shares forfeited

 

(212,296)

 

$

6.16

 

Nonvested at April 1, 2017

 

1,148,500

 

$

4.84

 

 

CEO  
Stock-Based Compensation  
Schedule of assumptions used to determine fair value of stock options

The following significant assumptions were used as of October 29, 2014:

 

 

 

 

 

Stock price

   

$

16.00

 

Exercise price

 

$

16.00

 

Expected option term

 

 

6.0

years

Expected volatility

 

 

55.0

%

Risk-free interest rate

 

 

1.8

%

Expected annual dividend yield

 

 

0

%